Verified· 2 sources

Addex Pharma SA

Summary

About the company

Addex Pharma SA is a clinical-stage pharmaceutical company focused on the development and commercialization of orally available small-molecule allosteric modulators for neurological disorders. Its pipeline includes programs such as dipraglurant (mGlu5 NAM), ADX71149 (mGlu2 PAM) and GABAB PAM candidates targeting indications including substance use disorder and chronic cough.

AI-generated

Offering

Products & services

Industry:Pharmaceutical Industry

✓ Offered3

Research and development of allosteric modulators

Research and development of allosteric modulators for neurological disorders, including a preclinical and clinical pipeline with small molecules.

Development and marketing of drug candidates

Development and marketing of clinical and preclinical drug candidates, including Dipraglurant, ADX71149 and GABAB-PAM programmes.

Research and development of drug substance programmes for neurological diseases

Research programmes for neurological diseases and related indications, including stroke/TBI recovery, addiction disorders and chronic cough.

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Addex Pharma SA

About the company

Products & services

Looking for direct email addresses and phone numbers?

Addex Pharma SA

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

Addex Pharma SA in comparison

Industry comparisons are coming soon

Similar companies